578 related articles for article (PubMed ID: 1856266)
1. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome.
Ross JL; Long LM; Feuillan P; Cassorla F; Cutler GB
J Clin Endocrinol Metab; 1991 Aug; 73(2):355-9. PubMed ID: 1856266
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in Turner's syndrome and the influence of pubertal development.
Nadeem M; Roche EF
Acta Paediatr; 2014 Jan; 103(1):e38-42. PubMed ID: 24354573
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea.
Davies MC; Gulekli B; Jacobs HS
Clin Endocrinol (Oxf); 1995 Dec; 43(6):741-6. PubMed ID: 8736278
[TBL] [Abstract][Full Text] [Related]
4. Normal DXA bone mineral density but frail cortical bone in Turner's syndrome.
Zuckerman-Levin N; Yaniv I; Schwartz T; Guttmann H; Hochberg Z
Clin Endocrinol (Oxf); 2007 Jul; 67(1):60-4. PubMed ID: 17437508
[TBL] [Abstract][Full Text] [Related]
5. Decreased metabolic clearance of endogenous growth hormone and specific alterations in the pulsatile mode of growth hormone secretion occur in prepubertal girls with Turner's syndrome. Genentech Collaborative Group.
Veldhuis JD; Sotos JF; Sherman BM
J Clin Endocrinol Metab; 1991 Nov; 73(5):1073-80. PubMed ID: 1939522
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
Bergmann P; Valsamis J; Van Perborgh J; De Schepper J; Van Vliet G
J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
[TBL] [Abstract][Full Text] [Related]
8. Bone maturation in girls with Turner's syndrome.
Even L; Bronstein V; Hochberg Z
Eur J Endocrinol; 1998 Jan; 138(1):59-62. PubMed ID: 9461317
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density in Turner's syndrome--a longitudinal study.
Shaw NJ; Rehan VK; Husain S; Marshall T; Smith CS
Clin Endocrinol (Oxf); 1997 Sep; 47(3):367-70. PubMed ID: 9373461
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome.
Pasquino AM; Passeri F; Pucarelli I; Segni M; Municchi G
J Clin Endocrinol Metab; 1997 Jun; 82(6):1810-3. PubMed ID: 9177387
[TBL] [Abstract][Full Text] [Related]
11. Turner syndrome adolescents receiving growth hormone are not osteopenic.
Neely EK; Marcus R; Rosenfeld RG; Bachrach LK
J Clin Endocrinol Metab; 1993 Apr; 76(4):861-6. PubMed ID: 8473397
[TBL] [Abstract][Full Text] [Related]
12. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
[TBL] [Abstract][Full Text] [Related]
13. [Turner's syndrome: subjects with a normal body mass at birth grow taller than born small for gestational age].
Wiśniewski A; Stupnicki R; Milde K; Szufladowicz-Woźniak J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):131-4. PubMed ID: 16813719
[TBL] [Abstract][Full Text] [Related]
14. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
[TBL] [Abstract][Full Text] [Related]
15. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
16. [Spontaneous growth of girls with Turner's syndrome until 6 years of age].
Wiśniewski A; Milde K; Stupnicki R
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):7-11. PubMed ID: 16704855
[TBL] [Abstract][Full Text] [Related]
17. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone.
Bertelloni S; Cinquanta L; Baroncelli GI; Simi P; Rossi S; Saggese G
Horm Res; 2000; 53(2):72-6. PubMed ID: 10971092
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome.
Copeland KC
J Clin Endocrinol Metab; 1988 Jun; 66(6):1278-82. PubMed ID: 3372687
[TBL] [Abstract][Full Text] [Related]
19. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
[TBL] [Abstract][Full Text] [Related]
20. Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner's syndrome.
Han TS; Cadge B; Conway GS
Clin Endocrinol (Oxf); 2006 Nov; 65(5):643-7. PubMed ID: 17054467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
